For the first time, a research team has demonstrated an artificial intelligence semiconductor technology that integrates the ...

Logdotzip plays Minecraft Prison #18 where item swapping with random players creates unpredictable survival chaos. He was fooling around on the edge - then his hand suddenly slipped Coffee found to ...

Xbox Game Pass and the Counting Crows share a mantra: You don't know what you've got 'til it's gone. Microsoft's games-on-demand service regularly adds new games to its library, but it just as ...

There has been a sharp rise in so-called "nudification" technology. These AI-powered tools can generate realistic fake images and videos that depict people as undressed, often without their knowledge ...

When Annie Benjamin invested $99,000 in an annuity 10 years ago, she trusted the insurance company to provide her with retirement income. She also relied on the company’s regulator to ensure the ...

SunZia has quietly begun sending enormous amounts of wind power to California, as President Donald Trump works to thwart the wind industry. The largest renewable energy project ever built in the ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

CEDAR RAPIDS, Iowa (KCRG) - Alliant Energy is planning a new natural gas-powered generating station in Cedar Rapids, a move the company says will help meet customer demand while supporting a broader ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...